These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6703676)

  • 1. Hemodialysis elimination rates and clearance of gentamicin and tobramycin.
    Matzke GR; Halstenson CE; Keane WF
    Antimicrob Agents Chemother; 1984 Jan; 25(1):128-30. PubMed ID: 6703676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gentamicin clearance during hemodialysis: a comparison of high-efficiency cuprammonium rayon and conventional cellulose ester hemodialyzers.
    Agarwal R; Toto RD
    Am J Kidney Dis; 1993 Aug; 22(2):296-9. PubMed ID: 8352256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased dosage requirements of tobramycin and gentamicin for treating Pseudomonas pneumonia in patients with cystic fibrosis.
    Mann HJ; Canafax DM; Cipolle RJ; Daniels CE; Zaske DE; Warwick WJ
    Pediatr Pulmonol; 1985; 1(5):238-43. PubMed ID: 4069813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance of gentamicin during hemodialysis: comparison of four artificial kidneys.
    Halpren BA; Axline SG; Coplon NS; Brown DM
    J Infect Dis; 1976 Jun; 133(6):627-36. PubMed ID: 932490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in gentamicin clearance between high-efficiency hemodialyzers.
    Agarwal R; Cronin RE
    Am J Kidney Dis; 1994 Jan; 23(1):47-51. PubMed ID: 8285197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of serum gentamicin concentrations in patients undergoing hemodialysis.
    Goetz DR; Pancorbo S; Hoag S; Bloom P
    Am J Hosp Pharm; 1980 Aug; 37(8):1077-83. PubMed ID: 7405935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosing.
    Sowinski KM; Magner SJ; Lucksiri A; Scott MK; Hamburger RJ; Mueller BA
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):355-61. PubMed ID: 18235142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentamicin and tobramycin pharmacokinetics in pediatric bone marrow transplant patients.
    Jacobson PA; West NJ; Price J; Hutchinson RJ
    Ann Pharmacother; 1997 Oct; 31(10):1127-31. PubMed ID: 9337435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of gentamicin serum concentration rebound following hemodialysis.
    Catolico MM; Campbell S; Jones WN; Logan JL
    Drug Intell Clin Pharm; 1987 Jan; 21(1 Pt 1):46-9. PubMed ID: 3816558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].
    Lode H; Grunert K; Kemmerich B; Koeppe P
    Adv Clin Pharmacol; 1978; 15():35-44. PubMed ID: 676877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia.
    Etzel JV; Nafziger AN; Bertino JS
    Antimicrob Agents Chemother; 1992 Mar; 36(3):679-81. PubMed ID: 1622185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects.
    Schwartz SN; Pazin GJ; Lyon JA; Ho M; Pasculle AW
    J Infect Dis; 1978 Oct; 138(4):499-505. PubMed ID: 712111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gentamicin and tobramycin Kinetics.
    Counts GW; Blair AD; Wagner KF; Turck M
    Clin Pharmacol Ther; 1982 May; 31(5):662-8. PubMed ID: 7075115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of gentamicin in hemodialysis patients: a comparative study between diabetic and non-diabetic patients.
    Al-Homrany MA; Irshaid YM; El Sherif AK; Omar HA
    Int Urol Nephrol; 2009; 41(3):663-9. PubMed ID: 18766456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay of gentamicin and tobramycin in sera of patients by gas-liquid chromatography.
    Mayhew JW; Gorbach SL
    Antimicrob Agents Chemother; 1978 Dec; 14(6):851-55. PubMed ID: 369455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
    Vercaigne LM; Ariano RE; Zacharias JM
    Clin Pharmacokinet; 2004; 43(3):205-10. PubMed ID: 14871157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of gentamicin pharmacokinetics in patients hemodialyzed with high-flux polysulfone membranes.
    Amin NB; Padhi ID; Touchette MA; Patel RV; Dunfee TP; Anandan JV
    Am J Kidney Dis; 1999 Aug; 34(2):222-7. PubMed ID: 10430966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodialyzer clearances of gentamicin, kanamycin, tobramycin, amikacin, ethambutol, procainamide, and flucytosine, with a technique for planning therapy.
    Christopher TG; Blair AD; Forrey AW; Cutler RE
    J Pharmacokinet Biopharm; 1976 Oct; 4(5):427-41. PubMed ID: 1003328
    [No Abstract]   [Full Text] [Related]  

  • 20. Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.
    Teigen MM; Duffull S; Dang L; Johnson DW
    J Clin Pharmacol; 2006 Nov; 46(11):1259-67. PubMed ID: 17050791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.